Vudalimab Biosimilar - Research Grade
Vudalimab Biosimilar - Research Grade
Product Information:ichorbio’s vudalimab biosimilar is for Research Use Only (RUO) Click here to view ichorbio's complete list of anti-PD-1 antibodies and biosimilars.
Target:PD-1 and CTLA-4
Size:This biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg
Isotype:Human IgG1(N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa
Host:CHO Cells
Species Reactivity:Human
Specificity:Detects human PD-1 and human CTLA-4.
Purification Method:This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration:5mg/ml
Formulation:20mM His/Asp, pH 5.0,Contains no stabilizers or preservatives.
Purity:>95% by SDS-PAGE
Endotoxin:≤ 1.0 EU/mg as determined by the LAL method
StorageThis antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
Applications:Functional Assays
Application Notes:This biosimilar is for research use only (RUO).
Concentration | 14.03mg/ml |
---|---|
isotype | Human IgG1(N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa |
Host | CHO Cells |